➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Baxter
Mallinckrodt
Harvard Business School
Express Scripts

Last Updated: June 20, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: CABOTEGRAVIR; RILPIVIRINE


Email this page to a colleague

« Back to Dashboard

CABOTEGRAVIR; RILPIVIRINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Viiv Hlthcare CABENUVA KIT cabotegravir; rilpivirine SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 212888 NDA ViiV Healthcare Company 49702-240-15 1 KIT in 1 CARTON (49702-240-15) * 3 mL in 1 VIAL * 3 mL in 1 VIAL 2021-01-21
Viiv Hlthcare CABENUVA KIT cabotegravir; rilpivirine SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 212888 NDA ViiV Healthcare Company 49702-253-15 1 KIT in 1 CARTON (49702-253-15) * 2 mL in 1 VIAL * 2 mL in 1 VIAL 2021-01-21
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
McKesson
Moodys
Baxter
Boehringer Ingelheim